MEGAN CANNON: Open Payments
NPI 1871885616 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,732 in 96 payments from 26 companies in 2025. Trend: 2023 $2,438 · 2024 $1,699 · 2025 $1,732
Food & beverage: $1,732
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $294 |
| Novo Nordisk Inc | 10 | $184 |
| PFIZER INC. | 7 | $157 |
| Amgen Inc. | 13 | $150 |
| AstraZeneca Pharmaceuticals LP | 4 | $137 |
| Lilly USA, LLC | 9 | $123 |
| Lundbeck LLC | 7 | $118 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Astellas Pharma US Inc | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
Products named: UBRELVY, NURTEC ODT, REXULTI, AIRSUPRA, QULIPTA, Wegovy, TRELEGY ELLIPTA, EVENITY.
Industry payments across VA — which companies pay providers there.
